Literature DB >> 7284405

Interaction of some trialkyl phosphorothiolates with acetylcholinesterase. Characterization of inhibition, aging and reactivation.

B Clothier, M K Johnson, E Reiner.   

Abstract

The reaction of bovine erythrocyte acetylcholinesterase (acetylcholine acetylhydrolase, EC 3.1.1.7) with a set of structurally related phosphorothiolates was studied in order to investigate the properties of the phosphorylated enzymes and to identify the leaving group. OOS- and OOS-trimethyl phosphorothiolates and their triethyl analogues inhibit acetylcholinesterase reversibly and by progressive inhibition, and the phosphorylated enzymes undergo both spontaneous reactivation and aging. For each compound the enzyme-inhibitor dissociation constant, and the rate constants for inhibition (ka), reactivation and aging have been derived. The OOS-compounds are more potent inhibitors than the OOS-compounds, and the derived inhibited enzymes reactivate and age faster. By comparing reactivation and aging rate constants with those obtained from phosphorylated enzymes of known structure it was concluded that the leaving group of during phosphorylation is the S-alkyl. SSS-trimethyl and -triethyl phosphorothiolates also form reversible complexes and inhibit the enzyme progressively. With these inhibitors the phosphorylated enzymes did not reactivate either spontaneously or in response to oximes under conditions successful for the other inhibitors. The ka values (37 degrees C, pH 7.4) range from 30 M-1 X min-1 (OOS-trimethyl phosphorothiolate) to 6.7 X 10(3) M-1 X min-1 (OOS-triethyl phosphorothiolate) as compared to 1.25 X 10(5) M-1 X min-1 determined for isomalathion (O, S-dimethyl S-(1,2-dicarbethoxyethyl)-phoshporodithioate), which was used as one of the reference compounds. If the inhibitory potency of the trialkyl phosphorothiolates is calculated from measurements made after a fixed preincubation time the results in ka values will be misleading.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7284405     DOI: 10.1016/0005-2744(81)90175-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Constructs of human neuropathy target esterase catalytic domain containing mutations related to motor neuron disease have altered enzymatic properties.

Authors:  Nichole D Hein; Jeanne A Stuckey; Shirley R Rainier; John K Fink; Rudy J Richardson
Journal:  Toxicol Lett       Date:  2010-04-09       Impact factor: 4.372

2.  Inhibition of serum cholinesterase by trialkylphosphorothiolates.

Authors:  L Franciskovic; Z Radic; E Reiner
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

3.  Novel Organophosphate Ligand O-(2-Fluoroethyl)-O-(p-Nitrophenyl)Methylphosphonate: Synthesis, Hydrolytic Stability and Analysis of the Inhibition and Reactivation of Cholinesterases.

Authors:  Chih-Kai Chao; S Kaleem Ahmed; John M Gerdes; Charles M Thompson
Journal:  Chem Res Toxicol       Date:  2016-10-17       Impact factor: 3.739

4.  Modulation of macrophage protease activity by acute administration of O,O,S trimethyl phosphorothioate.

Authors:  K E Rodgers; D D Ellefson
Journal:  Agents Actions       Date:  1990-03

5.  Dimethylphosphorothioates. Reaction with malathion and effect on malathion toxicity.

Authors:  R D Verschoyle; E Reiner; E Bailey; W N Aldridge
Journal:  Arch Toxicol       Date:  1982-03       Impact factor: 5.153

6.  An enzyme test for determining isomalathion impurities in water-dispersible powders of malathion.

Authors:  E Reiner; Z Radić
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408

7.  Kinetics and mechanism of inhibition of serine esterases by fluorinated aminophosphonates.

Authors:  G F Makhaeva; A Y Aksinenko; V B Sokolov; I I Baskin; V A Palyulin; N S Zefirov; N D Hein; J W Kampf; S J Wijeyesakere; R J Richardson
Journal:  Chem Biol Interact       Date:  2009-12-23       Impact factor: 5.192

8.  Crystal structure of patatin-17 in complex with aged and non-aged organophosphorus compounds.

Authors:  Sanjeeva J Wijeyesakere; Rudy J Richardson; Jeanne A Stuckey
Journal:  PLoS One       Date:  2014-09-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.